Preview Citation

Download

Bailey, M. (2016-04). Oral BG-12 for Relapsing-Remitting Multiple Sclerosis, Part I: The DEFINE Trial. In 50 Studies Every Neurologist Should Know. Oxford, UK: Oxford University Press. Retrieved 19 Oct. 2019, from https://oxfordmedicine.com/view/10.1093/med/9780199377527.001.0001/med-9780199377527-chapter-16.